Processa Pharmaceuticals's total assets for Q4 2025 were $7.81M, an increase of 3.02% from the previous quarter. PCSA total liabilities were $2.24M for the fiscal quarter, a 27.71% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.